ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 204,400 shares, a decrease of 11.1% from the April 30th total of 229,900 shares. Based on an average daily volume of 159,600 shares, […]
Marathon Capital Management trimmed its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 2.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 69,820 shares of the specialty pharmaceutical company’s stock after selling 1,850 shares during the quarter. ANI Pharmaceuticals accounts for approximately 1.0% of Marathon Capital Management’s investment portfolio, making the stock […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 261,600 shares, an increase of 5.0% from the February 29th total of 249,100 shares. Based on an average daily trading volume, of 134,700 […]